DON’T miss out the care for patients’ bone health while they are living longer with the improved treatment.
Metastatic bone disease imposes a considerable burden in physical and emotional aspects on patients with prostate cancer and healthcare providers.
During the lunchtime, take a look at the burden, management, and therapeutic options for skeletal risks.
And also hear from the oral surgeon’s updates on the solutions to the oral complications from bone-targeting agents.
This session aims to focus on bone to make the treatment for metastatic prostate cancer an integral care for patients.
2017-08-20 5.兒童大樓6F藍廳 (Sapphire Hall)
時間主題
12:00 ~ 12:30
Improving care for bone health in patients with prostate cancer
講者: 陳忠信 座長: 張延驊
12:30 ~ 13:00
Experience in managing ONJ in patients treated with bone-targeting agents
講者: 陳畊仲 座長: 張延驊